Results 171 to 180 of about 111,238 (263)

Feasibility and signal quality of the Minder® implantable continuous EEG monitoring® system compared to 10–20 scalp electrodes over extended monitoring periods

Epilepsia, EarlyView.
Abstract Objective To evaluate the signal quality of the Minder implantable continuous EEG monitoring (iCEM) system compared to traditional scalp EEG in the context of long‐term, continuous monitoring in individuals with epilepsy. Methods Twenty‐six patients implanted with the Minder iCEM system (November 2019 to July 2023) underwent 7‐day video‐EEG co‐
Taneeta Mindy Ganguly, Alan Lai, Andrew Niemiec, Tracy Cameron, Erin C. Conrad, Ramya Raghupathi, Colin Ellis, Amy J. Halliday, Lisa Gillinder, Udaya Seneviratne, Patrick Kwan, Piero Perucca, Aileen McGonigal, Sara Vogrin, Holly Fontenot, Mark J. Cook   +15 more
wiley   +1 more source

Rapidly Recurrent Retroperitoneal Cystic Lesion With Mass Effect in a Kidney Transplant Recipient: A Diagnostic and Management Challenge. [PDF]

Cureus
Barbosa ML, Samaniego J, Chepuru R, Findley JP, Gebhardt KE, Sestak E, Betman S, Olaitan O.   +7 more
europepmc   +1 more source

Introducing the D‐DAND scale: Development of a comprehensive caregiver‐administered tool for Dravet syndrome comorbidities

Epilepsia, EarlyView.
Graphical overview of the Dravet Disease–Associated Neuropsychiatric Disorders (D‐DAND) scale. The D‐DAND scale provides a caregiver‐based, comprehensive assessment of developmental and behavioral comorbidities in Dravet syndrome across six domains: motor abilities, language and social interaction, autonomies, academic skills, emotional/behavioral ...
Bernardo Dalla Bernardina, Francesca Offredi, Alessio Toraldo, Lisa Ouss, Delphine Breuillard, Mathilde Cozzo, Tommaso Lo Barco, Isabella Brambilla, Francesca Darra, Rima Nabbout   +9 more
wiley   +1 more source

Apathy in dementia with Lewy bodies: Frequency, correlates, and impact on patient and caregiver experiences. [PDF]

Parkinsonism Relat Disord
Barnes AL, Martinez-Nunez AE, Wang T, Li Z, Pontone GM, Armstrong MJ.   +5 more
europepmc   +1 more source

Pathological hippocampal–cortical hypersynchronization disrupts memory in temporal lobe epilepsy: A multimodal intracranial electroencephalographic–functional magnetic resonance imaging study

Epilepsia, EarlyView.
Abstract Objective Memory impairment is a common comorbidity in temporal lobe epilepsy (TLE) and is thought to arise from hippocampal dysfunction and disrupted interactions within a distributed memory network involving medial temporal, frontal, and parietal cortical regions.
Ruxue Gong, Xiaolong Peng, Rebecca W. Roth, Haris Rashid, William Yun, Daniel L. Drane, Leonardo Bonilha, Lisa McTeague, Ezequiel Gleichgerrcht   +8 more
wiley   +1 more source

We See That Plastics Are Persistent. But Should We Treat Them Universally as a POP? [PDF]

Environ Sci Technol
Maurer-Jones MA, Kalita NK.
europepmc   +1 more source

Developmental pathways to autism in tuberous sclerosis complex: Evidence from a longitudinal cohort

Epilepsia, EarlyView.
Abstract The association between autism spectrum disorder (hereafter referred to as autism) and tuberous sclerosis complex (TSC) is well established, yet the developmental pathways linking genetic mutation, cortical pathology, and epilepsy with autism remain unclear. The Tuberous Sclerosis 2000 Study recruited children newly diagnosed with TSC (N = 125)
Fiona S. McEwen, Abigail K. Runicles, Holan Liang, Emma Woodhouse, Lisa Underwood, Elizabeth Shephard, Edward D. Barker, Fintan Sheerin, Juul W. Steenbruggen, Tuberous Sclerosis 2000 Study Group, John R. W. Yates, Charlotte Tye, Patrick F. Bolton   +12 more
wiley   +1 more source

A Phase I study of the pharmacokinetics (PK), bioavailability, dose proportionality, safety, and tolerability of topiramate injection compared to Oral topiramate in healthy adult participants

Epilepsia, EarlyView.
Abstract This Phase I study evaluated the safety, tolerability, and pharmacokinetics of a 30‐min topiramate injection (intravenous [IV] TPM) infusion compared with oral topiramate (oral TPM) in healthy adult participants. In this randomized, open‐label, dose escalation, crossover study with 37 healthy participants received single doses of 50, 100, or ...
Adeboye O. Bamgboye, James C. Cloyd, Bernard D. King, Lisa D. Coles   +3 more
wiley   +1 more source

Summary of Research: Risdiplam Treatment Following Onasemnogene Abeparvovec in Individuals with Spinal Muscular Atrophy: A Multicenter Case Series. [PDF]

Adv Ther
Svoboda MD, Kuntz N, Leon-Astudillo C, Byrne BJ, Krueger J, Kwon JM, Sieburg C, Castro D.   +7 more
europepmc   +1 more source